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Abstract
First two decades of the twenty-first century are characterised by epidemics of non-communicable diseases such as 
many hundreds of millions of patients diagnosed with cardiovascular diseases and the type 2 diabetes mellitus, breast, 
lung, liver and prostate malignancies, neurological, sleep, mood and eye disorders, amongst others. Consequent socio-
economic burden is tremendous. Unprecedented decrease in age of maladaptive individuals has been reported. The 
absolute majority of expanding non-communicable disorders carry a chronic character, over a couple of years progressing 
from reversible suboptimal health conditions to irreversible severe pathologies and cascading collateral complications. 
The time-frame between onset of SHS and clinical manifestation of associated disorders is the operational area for an 
application of reliable risk assessment tools and predictive diagnostics followed by the cost-effective targeted prevention 
and treatments tailored to the person.
This article demonstrates advanced strategies in bio/medical sciences and healthcare focused on suboptimal health condi-
tions in the frame-work of Predictive, Preventive and Personalised Medicine (3PM/PPPM). Potential benefits in health-
care systems and for society at large include but are not restricted to an improved life-quality of major populations and 
socio-economical groups, advanced professionalism of healthcare-givers and sustainable healthcare economy. Amongst 
others, following medical areas are proposed to strongly benefit from PPPM strategies applied to the identification and 
treatment of suboptimal health conditions:
• Stress overload associated pathologies




• Inflammatory disorders, wound healing and pain man-
agement with associated complications
• Metabolic disorders and suboptimal body weight
• Cardiovascular pathologies
• Cancers




• Improved individual outcomes under pandemic condi-
tions such as COVID-19.
All authors equally contributed to the concepts presented in the 
paper
Extended author information available on the last page of the article
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TC  Traditional cupping
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3PM/PPPM  Predictive, Preventive and Personalised 
Medicine
Introduction
Epidemics of non‑communicable diseases 
in the twenty‑first century
First two decades of the twenty-first century are characterised 
by epidemics of non-communicable diseases such as many 
hundreds of millions of patients diagnosed with cardiovascular 
diseases (CVD) [1] and the type 2 diabetes mellitus (T2DM) 
[2]; some cancer types such as breast, lung, liver and prostate 
malignancies [3, 4]; and neurological, sleep, mood and eye 
disorders [5], amongst others. Consequent socio-economic 
burden is tremendous.
Unprecedented decrease in age of disordering 
individuals
Currently observed, there is an unprecedented in the age of 
individuals disease on non-communicable pathologies [5]. 
To this end, teenagers present a great portion of new cases 
diagnosed with T2DM annually [2]. There is an increasing 
prevalence of preventable eye disorders in high school students 
[6]. Mood disorders and suicide are frequently monitored in 
youth [5] as well as young strokes (15–50 years of age) with 
unknown aetiology [7]. Aggressive metastasising cancers are 
increasing reported for 20 + years old patients with particularly 
poor outcomes [4, 8–10].
Paradigm shift from reactive to predictive 
preventive and personalised medicine (3PM)
The paradigm shift from reactive medical services to pre-
dictive approach, targeted prevention and personalisation 
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of treatments has been proposed by the European Associa-
tion for Predictive, Preventive and Personalised Medicine 
(EPMA, Brussels, www. epman et. eu) to reverse above docu-
mented trends, to improve overall quality of medical services 
making them available for any socio-economic group in the 
society [11–15].
Modifiable risks and preventable illnesses: focus 
on suboptimal health measures
Particularly modifiable risk factors are instrumental for tar-
geted cost-effective prevention of illnesses in the population. 
To this end, inadequate lifestyle and dietary habits are most 
prominent examples of modifiable risks strongly associated 
with numerous of developing and progressing pathologies. 
Several parameters are indicative for that such as individu-
ally suboptimal (both overweight and underweight) body 
weight. Figure 1 highlights pathologies frequently associ-
ated on one hand with anorexic and on the other hand with 
obese phenotypes.
Currently applied weight loss programmes raise questions 
and concerns regarding individually adapted recommenda-
tions and individual health benefits for persons undergoing 
such as programme. To this end, a recently study performed 
in the USA which involved 20,002 adults has analysed the 
efficacy of receiving weight-related advice from healthcare 
professionals: surprisingly, patients who reported receiv-
ing weight-related advice, achieved worse weight outcomes 
a year later, compared to unsupervised patients [16]. Per 
evidence, individually optimal weight as one of the criti-
cal health parameters demonstrates the basic principle of 
personalised medicine, namely “ONE SIZE does not FIT 
ALL” being strongly dependent on the individual genetic 
predisposition, geographic origin, cultural and nutritional 
habits, amongst other lifestyle measures.
Health, as defined by the World Health Organisation, is 
“a state of complete physical, mental, and social well-being 
and not merely the absence of disease or infirmity” (WHO) 
[17]. For many, that level of health remains elusive -there is 
an increasing number of individuals worldwide who report 
general malaise even in the absence of a diagnosable disor-
der [18]. A full evaluation of health conditions is necessary 
for the effective implementation of public health interven-
tion [19].
However, there are persons who complain poor healthy 
perception but not in diagnosable disorders. This intermedi-
ate state between health and a diagnosable disease is known 
as suboptimal health status (SHS) [20, 21].
SHS is a reversible borderline condition between opti-
mal health and diseases, characterised by declines in vital-
ity, physiological function and capacity for self-adaptation, 
which does not meet any criteria of diseases but suffer from 
the perception of health complaints, general weakness and 
low energy. Individuals with SHS have predispositions to 
physical or mental diseases, especially non-communicable 
diseases. The majority of non-communicable disorders 
have a chronic feature by progressing over a couple of years 
from a reversible suboptimal health condition to irreversible 
pathology with corresponding complications [22].
On behalf of the Suboptimal Health Study Consortium/
SHSC, this multiple centre dedicated working group pro-
vides a deep analysis on the topic SHS from the perspectives 
of Predictive, Preventive and Personalised Medicine (PPPM) 
considering the multifaceted aspects of both “health care” 
and “disease prevention” practices including (1) definition 
of SHS; (2) identification and quantification of reversible 
Fig. 1  Anorexic versus obese 
phenotype: the paradox of the 
health risks similarity; the 
figure is adapted from [5]
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damage to the health; (3) the status quo of suboptimal health 
predictive diagnostic tools; (4) avoiding of under- and over-
diagnosis with significant economic impacts to healthcare; 
(5) suboptimal health status, risk factors and risk group; (6) 
individualised preventive measures; (7) treatment algorithms 
tailored to the person; and (8) outlook: conventional and 
traditional medicine — a “hand-in-hand” collaboration ben-
efiting the patient and healthcare at large.
Definition of SHS
Suboptimal Health Status (SHS) is “an overall physical 
status between health and illness characterised by the per-
ception of health complaints, chronic fatigue, and a con-
stellation of physical symptoms such as the cardiovascular 
system, the digestive system, the immune system, and men-
tal status; lasting for at least 3 months” [18, 21]. Although 
SHS is not a disease state, several studies have suggested 
that SHS might precede the occurrence of chronic diseases, 
including cardiovascular diseases (CVD) [23, 24] and type 2 
diabetes mellitus (T2DM) [25, 26]. From the perspective of 
predictive, preventive, and personalised medicine (PPPM), 
the concept of SHS reflects the viewpoint that chronic dis-
eases can be effectively predicted and prevented before the 
occurrence of a clinical manifestation of severe pathologies 
[27]. PPPM is an integrative concept in the health care sector 
that enables to predict individual predisposition before the 
onset of disease, to provide targeted preventive measures and 
to create personalised treatment algorithms tailored to the 
person [5, 15]. Chronic diseases, such as CVD and T2DM, 
are treated after disease onset, which is a very much delayed 
approach in terms of PPPM. As a subclinical, reversible 
stage of chronic diseases, SHS plays a significant role in 
the prediction and prevention of chronic diseases in terms 
of PPPM [5].
SHS may not necessarily represent the condition known 
as either early stage or preclinical period of illness, but it is 
commonly defined as the period preceding the occurrence 
of clinical manifestations of diseases [19–21]. Individuals in 
early stage or preclinical period usually need the interven-
tions with specific therapies that enable to prevent or delay 
the onset of the disease. People with SHS are considered to 
require no specific clinical treatment but may be at a high 
risk for some diseases. It has been reported that only 23% 
people in SHS sought for medical help, and nearly 80% 
of individuals who complained of SHS-related symptoms 
showed no improvements within 6 months [28]. It is, there-
fore, urgent to promote the actions to identify individuals 
with SHS from the perspectives of PPPM [29].
SHS, by reference to its characteristics, is understood 
to be associated with the following syndromes: general 
weakness, unexplained medical syndrome (UMS), chronic 
fatigue syndrome (CFS), myalgic encephalomyelitis (ME), 
post-viral fatigue syndrome (PVFS), Flammer Syndrome, 
and chronic fatigue immune dysfunction syndrome (CFIDS) 
[18, 30]. To improve the healthcare services from the per-
spective of PPPM, more studies are needed to clarify the 
SHS-associated health damages and dysfunctions, by which 
individuals exposed to SHS-induced damage will receive 
specific remedy.
A non-invasive screening tool for measuring SHS has 
been developed: suboptimal health status questionnaire-25 
(SHSQ-25), and it has been validated in African [31, 32], 
European [24], and Asian populations [27, 29, 33]. The 
SHSQ-25 accounts for the multidimensionality of SHS by 
encompassing five domains: fatigue, the cardiovascular sys-
tem, the digestive system, the immune system, and mental 
status, with 25 supporting elements [29]. Figure 2 highlights 
SHS as being crucial to advance predictive preventive, and 
personalised medical care tailored to the person vulnerable 
to non-communicable diseases.
Since early detection followed by appropriate interven-
tion is important for prevention from the onset of diseases, it 
should be requested for clinicians to shift from the perspec-
tive of delayed intervention approaches to early screening of 
individuals with SHS [31]. The heterogeneity and uncontrol-
lability of health-related perceptions and inconsistent pheno-
types of health complaints make it difficult to discriminate 
the persons in SHS from general populations. Commonly, 
identification of the five domains of SHS is of interest for 
health improvement: fatigue, cardiovascular system, diges-
tive tract, immune system, and mental state [20, 27].
Established approaches to identify 
and quantify reversible damage to health
Health scales and questionnaires are effective measurement 
instruments for recognition of reversible damage to the 
health that are difficult to be measured directly [27]. Dur-
ing the past decades, health scales and questionnaires have 
been extensively used in measurement of various aspects 
of health such as different symptoms or the presence of a 
particular trait [34, 35], such as the “Suboptimal Health Sta-
tus Questionnaire-25 (SHSQ-25)” [27], “Cornell Medical 
Index (CMI) [36]”, and “12-item General Health Question-
naire (GHQ-12)” [37] et al. The SHSQ-25 was developed 
for investigating suboptimal health status (SHS), a revers-
ible damage condition to the health [27]. The SHSQ-25 
includes 25 items and encompasses 5 subscales: fatigue, 
the cardiovascular system, the digestive tract, the immune 
system, and mental status. Based on the influence of chronic 
stress on health, the preliminary SHSQ-25 was developed by 
methods including literature review, focus group discussions 
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and feedback from relevant medical staff such as physicians, 
health managers, pathophysiologists, and clinical epidemiol-
ogist. The questionnaire was tested in a large cross-sectional 
investigation confirmed the validity and reliability of the 
questionnaire [27].
The procedure of questionnaire development
The main procedure of questionnaire development includes: 
concepting → item → questionnaire. Before designing the 
questionnaire, the purpose of the research and theoretical 
hypothesis should be determined. The items of a newly 
developed questionnaire can come from several sources, 
such as established instruments, literature, focus group dis-
cussions, and expert opinions [27, 34]. After the items have 




been written, focus groups and expert panels are used again 
to discuss whether these items are relevant, clear, unam-
biguous, written in terms that are understood by potential 
respondents. After that, a preliminary health questionnaire is 
constructed based on the item pool. The investigator should 
consider the sequence of questions, logical structure, con-
venience for answer, and possible psychological impact 
on the respondents. Usually, a pilot study is performed to 
assess whether the questions are relevant and feasible for 
use. Based on the feedback of the respondents in the pilot 
study, the questionnaire is then revised, and the final version 
is formed.
To obtain valid responses, an appropriate scoring system 
for quantifying the responses should be used. It is suggested 
that using as many classes as they can be used for responses 
of health questionnaire [38]. Rating scales, which seem to 
have been first formalised by Likert, are widely used in the 
health and social sciences in the assessment of variables that 
cannot be measured directly [39, 40]. For example, all ques-
tions of the SHSQ-25 asked the individual to rate a specific 
statement on a five-point Likert-type scale (never or almost 
never, now and then, often, very often, and always) how 
often they suffered from various specific discomfort in the 
preceding 3 months [27].
Assessment of reliability of health scale
The two most fundamental and important characteristics of 
any measurement procedure are reliability and validity. A 
good measurement instrument should be stable and reliable, 
and the results of measurement should be reproducible. Reli-
ability refers to the extent to which a scale or questionnaire 
produces the same results using the same instruments under 
similar conditions [41]. There are two aspects of reliability, 
namely: external reliability and internal reliability. Exter-
nal reliability usually refers to the consistency of measure-
ment tools at different time. Internal reliability refers to if a 
measurement instrument measures a single concept, that is, 
the extent of internal consistency amongst the items of the 
instrument. There are different indices to measure reliabil-
ity including test–retest reliability, alternate form reliability, 
split-half reliability, and Cronbach’s alpha et al. Cronbach’s 
alpha is a widely used measure reliability that assesses the 
degree to which the items are related to each other; it meas-
ures a unified construct [42]. A Cronbach’s alpha coefficient 
greater than 0.70 are generally considered acceptable for 
group comparisons, and 0.90 for person-level comparisons 
[43].
Assessment validity of health scale
Validity is defined as the extent to which the instrument 
measures what it purports to measure [9]. There are two 
aspects of validity, namely: internal validity and external 
validity. Internal validity generally refers to the accuracy 
of inferences about whether one variable cause another. 
External validity refers to what extent can our results are 
able to accurately generalised to other participants or situa-
tions. There are several types of validity, including content 
validity, criterion validity, construct validity, discriminant 
validity and convergent validity. Construct validity is widely 
used to assess the validity of a given questionnaire, which 
reflect the degree to which an instrument measures the trait 
or theoretical construct that it is intended to measure. To 
establish the construct validity, investigator has to generate 
predictions based upon the hypothetical construct, and these 
predictions can be then tested to give support to the validity 
of the questionnaire [44]. Statistically, construct validity is 
usually tested through exploratory or confirmatory factor 
analysis [45, 46].
In summary, a well-developed health instrument is essen-
tial for predictive, preventive, and personalised medicine. To 
be useful, health measurement scales should be reliable and 
valid, and convenient for respondents to use.
Persons at high versus low risk: avoiding 
under‑ and over‑diagnosis with significant 
economic impacts to healthcare
Assessment of SHS has demonstrated the ability to predict 
the risk of certain chronic diseases, such as cardiovascu-
lar disease (CVD) [24]. Identification of persons at risk of 
developing chronic disease is an outcome shared by both 
SHS and Predictive, Preventive and Personalised Medicine 
(PPPM) [5, 27]. PPPM is a concept enabling the predic-
tion of a person’s predisposition to disease before its onset, 
followed by preventive measures delivered via personal-
ised treatment algorithms [13]. Reducing the prevalence 
of chronic diseases is urgent, especially considering that 
the estimated total global cost of CVD will increase from 
US$863 billion (2010) to over US$1044 billion by 2030 
[47].
The under- and over-diagnosis of chronic diseases, while 
dichotomous, both augment the substantial economic bur-
dens to healthcare by virtue of their respective sequelae [48]. 
Under-diagnosis is “the failure to recognise or correctly 
diagnose a disease or condition especially in a significant 
proportion of patients” [49], whilst over-diagnosis occurs 
when an individual is diagnosed with a disease that would 
have otherwise never caused them symptoms, harm, or early 
death, but are then exposed to treatments where the risks 
outweigh the benefits [48, 50]. In this paragraph, we dem-
onstrate how assessment of SHS identifies persons at high 
versus low risk: avoiding under- and over-diagnosis with 
significant economic impacts to healthcare, evidencing SHS 
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as the new gold standard in the global fight against chronic 
disease from the perspectives of PPPM.
Under‑diagnosis
Effective screening of chronic diseases, such as T2DM or 
prediabetes, is key in PPPM quest to curb the prevalence of 
non-communicable diseases [13]. Early identification ena-
bles prompt treatment and delays long-term complications 
[25]. This is especially important considering T2DM has 
entered the top 10 causes of death worldwide [51], with a 
projected trajectory for its prevalence to reach 500 million 
by 2025–2030 [15]. Furthermore, T2DM is prognosticated 
to reach pandemic proportions in 10–20 years, contributing 
to a potential “economic disaster of health care systems on 
a global scale” [5]. Despite this, T2DM is still frequently 
under-diagnosed [52]. A valid and cost-effective screening 
tool is paramount [27]. Amongst the new methods of screen-
ing instruments, SHS deserves special attention [27].
Case study one — Incorporation of suboptimal health 
status as a potential risk assessment for type 2 diabetes mel-
litus: a case control study in a Ghanaian population
A cross-sectional study conducted in Ghana incorporated 
SHS as a potential risk assessment for T2DM [25]. Patients 
with diagnosed T2DM and healthy controls (n = 241:264) 
respectively, completed the SHSQ-25 questionnaire, and 
were concurrently assessed for anthropometric, clinical, and 
biochemical parameters [25]. In healthy individuals, SHS 
was able to discriminate between highly at-risk individuals 
and low risk individuals (median score > 21 represents high 
SHS (poor health) whereas median score < 21 represents low 
SHS (good health)) [25]. This study revealed both systolic 
and diastolic blood pressure to be significantly associated 
with high SHS scores [25], an alarming finding considering 
high blood pressure is the main risk factor or T2DM and 
CVD [25]. Moreover, undiagnosed hypertension was com-
mon amongst the participants [25]. In an ideal setting, and in 
line with PPPM, receiving a high SHS score should prompt 
individuals to have their clinical/biochemical markers tested 
at a healthcare centre. Further, an individual with a high 
SHS score may have undiagnosed, asymptomatic T2DM, 
or its related co-morbidities, that requires urgent interven-
tion or treatment. In either case, identification of person’s 
at high risk through SHS provides the opportunity for pre-
ventive treatment by way of dietary/lifestyle modifications 
prescribed by healthcare professionals. The study also found 
that amongst T2DM sufferers, there was poor management 
of risk factors, with the majority of T2DM patients having 
higher than recommended levels of fasting plasma glucose 
and HbA1c levels (i.e. > 7 mmol/l and > 7.2 mmol/l, respec-
tively) [25]. Many of these patients are at risk of developing 
co-morbidities and complications as a result of inadequate 
management [25].
Case study two — Suboptimal health status as an inde-
pendent risk factor for T2DM in a community-based cohort: 
the China suboptimal health cohort study
The China Suboptimal Health Cohort Study (COACS) 
is a longitudinal study initiated in 2013 to understand the 
impact of SHS on the progress of T2DM [21]. A recent 
prospective study from the COACS performed a baseline 
evaluation of 3635 participants in 2013–2014, consisting of 
a medical history, standardised physical evaluation (such as 
measuring BMI and blood pressure) laboratory assessment 
of T2DM (such as fasting glucose level and total choles-
terol), and measurement of SHS using the SHSQ-25 [53]. 
T2DM outcomes were then followed up annually from 
2013 to 2017 [26]. The study aimed to compare the dif-
ference in cumulative incidence between SHS groups and 
also investigated the relationship between SHS levels and 
risk of T2DM onset [26]. Over the course of the study, 61 
participants developed T2DM, whilst 3574 remained in good 
health. Using logistic regression models, SHS scores were 
entered as quartiles (Q), with the lowest quartile as the refer-
ence [26]. The results showed that participants with higher 
levels of SHS had a significantly higher risk of T2DM [16]. 
Participants in the highest quartile of SHS had a 1.7-fold risk 
of developing T2DM when compared to the lowest quartile 
[26]. Compared with the lowest level of SHS (Q1), the Q4, 
Q3, and Q2 were found to be associated with 1.7-, 1.6-, 
and 1.5-fold risks of developing T2DM, respectively [26], 
indicating that the risk will increase with the increasing SHS 
performance of an individual [26]. The potential applicabil-
ity of SHS as dynamic monitoring index for the development 
of T2DM should be considered [26]. Table 1 highlights rela-
tive risk of T2DM by quartile group of SHS.
The aforementioned examples demonstrate how SHS 
avoids the under-diagnosis of chronic diseases, in this case 
T2DM, by identifying and stratifying persons at risk [25, 
26]. In developing countries such as Ghana, routine screen-
ing for SHS by adoption of SHSQ-25 would serve to over-
come the economic barriers associated with a lack of labora-
tory tests and treatments, facilitating PPPM, thus having a 
significant impact to healthcare.
The under-diagnosis of T2DM is not limited to devel-
oping countries such as Ghana and China, however, with 
developed nations also severely affected. For example, the 
cost of undiagnosed diabetes in the USA in 2017 was esti-
mated to be $31.7 billion dollars, with prediabetes costing 
$43.4 billion [53]. The high cost of treating undiagnosed 
diabetes underscores the importance of screening for early 
detection and management [54] yet despite the screening 
recommendations by the American Diabetes Association 
(individuals over 45 and at-risk younger adults every three 
years) [55] between 2005 and 2012, less than half of these 
individuals were actually screened; a result attributed to the 
social determinants of health [56]. Compared to many other 
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survey instruments, the SHSQ-25 is a short, simple, and 
inexpensive tool to use; the implementation of which should 
be adopted as part of routine screening programs in both 
developing and developed nations. This will serve to avoid 
the high levels of under-diagnosis for chronic diseases, such 
as T2DM, through the identification of persons at high ver-
sus low risk with significant economic impact to healthcare.
Over‑diagnosis
Over-diagnosis has multiple negative effects on both patients 
and cost burden for healthcare systems; patients are exposed 
to unnecessary tests and treatments, and resources are 
wasted that could be better spent treating or prevent genu-
ine illness [48]. The cost of over-diagnosis is staggering, 
draining healthcare systems of billions of dollars each year 
[48]. For example, an estimated $200 billion is squandered 
on unneeded treatments in North America each year [48]. 
Over-diagnosis rests on the premise that diagnosis confers 
no benefit [57]. For example, diagnosis of a small, low-grade 
prostate cancer in an elderly man as a result of screening that 
leads to unnecessary treatments is considered over-diagno-
sis, as the cancer would never have caused problems for the 
patient in his lifetime [57].
Suboptimal health status rests on the premise that diag-
nosis does offer a benefit. Detecting SHS enables patient 
stratification by predicting an individual’s predisposition to 
disease, giving clinicians the opportunity to implement tar-
geted preventive measures before the actual onset of disease 
[18]. Identification of person’s at high versus low risk using 
SHS therefore avoids over-diagnosis, demonstrated in the 
examples below.
Case study three — Association of suboptimal health sta-
tus and cardiovascular risk factors in urban Chinese workers
A recent study analysed the association of SHS and 
cardiovascular risk factors in urban Chinese workers and 
found participants with high SHS scores had a higher 
risk of CVD than those with low scores [29]. Compared 
to the low SHS group, systolic and diastolic blood pres-
sure, plasma glucose, total cholesterol, triglyceride lev-
els, and BMI were significantly higher amongst the high 
SHS group (P < 0.001). In addition, serum cortisol lev-
els were much higher amongst the high SHS group than 
amongst the low SHS group (204.31 versus 161.33 ng/ml, 
P < 0.001) [29]. SHS is associated with cardiovascular risk 
factors and contributes to the development of cardiovascu-
lar disease [29]. Table 2 highlights relevance of SHS for 
cardiovascular disease.
Case study four — Association between ideal cardiovas-
cular health metrics and suboptimal health status in a Chi-
nese population
Another study explored the association between SHS and 
ideal cardiovascular health (CVH) metric scores. The study 
found higher ideal CVH metrics are associated with a lower 
prevalence of SHS, with subjects in the highest quartile of 
the ideal CVH metric summary score have a 57% reduced 
OR of having SHS compared to those in the lowest quartile 
[23]. The study found evaluation of SHS, combined with the 
analysis of seven cardiovascular health metrics as defined by 
the American Heart Association (smoking, physical activ-
ity, dietary intake, BMI, blood pressure, fasting blood glu-
cose, and total cholesterol) allows for risk classification of 
CVD [23]. Four metrics (smoking, physical inactivity, poor 
dietary intake, and blood pressure) were significantly associ-
ated with the risk of SHS. Conversely, three metrics (ideal 
dietary intake, ideal physical activity, and never smoked or 
quit smoking > 12 months) were shown to be independent 
protective factors of SHS [23]. This demonstrates that health 
behaviour plays an important role in contributing to the 
association between SHS and risk of cardiovascular events. 
These findings suggest that increasing ideal CVH metric 
score is a new independent protection factor of SHS [23].
Taken together, these studies provide examples that detec-
tion of SHS effectively stratifies patients at risk of CVD 
[24]. Moreover, it can be proposed that intervention of SHS 
together with maintaining ideal CVH could be an effective 
Table 1  Relative risk (RR) of T2DM incidents by quartile groups 
of SHS (26): SHS avoids under-diagnosis by identifying persons at 
high versus low risk, with significant economic impacts to healthcare; 
model 1, crude model; model 2, adjusting for age and gender; model 
3, model 2 + age, gender, smoking status, body mass index (BMI), 
systolic blood pressure (SBP), diastolic blood pressure (DBP), total 
cholesterol (TC), triglycerides (TG), low-density lipoprotein cho-
lesterol (LDLC), and high-density lipoprotein cholesterol (HDLC); 
model in female, model 2 + age, BMI, SBP, DBP, TC, LDLC, and 
HDLC. Statistically significant RRs are presented in italics
Models RRs of SHS (95% CI)
Q1 (SHS < 8) Q2 (SHS = 8–14) Q3 (SHS = 14–24) Q4 (SHS > 24)
Model 1 1.00 (ref) 1.80 (1.20–2.72) 1.98 (1.33–2.96) 1.93 (1.29–2.88)
Model 2 1.00 (ref) 1.61 (1.08–2.48) 1.71 (1.13–2.56) 1.80 (1.17–2.66)
Model 3 1.00 (ref) 1.54 (0.95–2.29) 1.62 (1.02–2.41) 1.71 (1.11–2.61)
Stratified analysis
Model in male 1.00 (ref) 1.72 (1.02–2.92) 1.72 (1.02–2.91) 1.73 (1.01–2.98)
Model in female 1.00 (ref) 1.69 (0.86–3.34) 1.90 (0.99–3.64) 1.93 (1.02–3.65)
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preventive strategy for CVD from the perspectives of PPPM 
[23].
In conclusion, we demonstrated that assessment of SHS 
identifies persons at high versus low risk: avoiding under- 
and over-diagnosis with significant economic impacts to 
healthcare in the following ways; higher SHS scores are 
associated with T2DM and CVD [25, 29]; SHS evaluation, 
in conjunction with modifiable risk factor analysis, allows 
for risk stratification of patients for T2DM and CVD [23, 
26]; increasing ideal CVH metrics score is a new independ-
ent protection factor of SHS [23]. These examples evidence 
SHS as the new standard in the global fight against chronic 
disease from the perspectives of PPPM. Effective interven-
tion of SHS may be a cost-effective and time-efficient way 
for preventing chronic diseases, such as T2DM and CVD.
The status quo of suboptimal health 
predictive diagnostic tools
Health‑related quality of life
The general concept of quality of life was initially consid-
ered a useful adjunct to traditional concepts of health and 
functional status [58]. It is a broad ranging concept compris-
ing in a complex way the persons’ physical health, psycho-
logical state, level of independence, social interconnections 
and their environmental relationships [58]. The question-
naire developed by the World Health Organisation (WHO) is 
the WHO Quality of Life-100 (WHOQOL-100). It consists 
of 25 facets (4 items per facet; the total items = 100) in six 
dimensions: (1) physiology, (2) psychology, (3) independ-
ence, (4) social relations, (5) environment, and (6) spiritual 
support, religion, and personal belief [58]. The WHO-
QOL-100 was further revised for studies on health-related 
quality of life for a given group, such as WHOQOL-Brief 
and WHOQOL-Old [59]. These questionnaires have good 
psychometric properties such as reliability, validity and 
responsiveness and have been used to assess generic quality 
of life issues affected by all health problems [60].
The 36-item-short form health survey questionnaire (SF-
36) is another popular instrument for evaluating health-
related quality of life (61). It includes eight multiple-item 
with subscales to evaluate physical function, social function-
ing, role limitations due to physical problems and emotional 
problems, mental health, vitality, pain, and general health 
perception [62].
Health-related quality of life, by definition, covers a 
broader range of health-related status. Thus, specific tools 
are needed for the studies focused on the suboptimal health 
status.
Suboptimal health status questionnaire‑25
The suboptimal health status questionnaire-25 (SHSQ-25) 
has been developed for measuring SHS and validated in 
three major ethnic groups: African, Chinese and Caucasian. 
“SHSQ-25 includes 25 items covering five dimensions: 
fatigue, the cardiovascular system, the digestive tract, the 
immune system, and mental status” [63] (Table 1). SHSQ-25 
questionnaire can be used in both health care and community 
settings to identify individuals who complain of poor health 
without a diagnosable condition [18, 31]. Each participant 
was asked to rate a statement on a 5-point Likert-type scale, 
based on how often they had experienced a particular com-
plaint in the previous 3 months: (1) never or almost never, 
(2) occasionally, (3) often, (4) very often, and (5) always. 
The raw scores of 1 to 5 on the SHSQ-25were recoded as 
0–4 [27]. Table 3 presents the specialised questionnaire 
SHSQ-25.
The SHSQ-25 is short and easy to complete and, there-
fore, an instrument suitable for use in both large-scale 
studies of the general population and routine health sur-
vey [20]. To date, SHSQ-25 as a practical SHS survey 
Table 2  Comparison of the 
cardiovascular risk factors 
between high and low SHS 
score group (29)
SHS suboptimal health status, SBP systolic blood pressure, DBP diastolic blood pressure, GLU plasma glu-
cose, TCH total cholesterol, TG triglyceride, HDLC high-density lipoprotein cholesterol, LDLC low-den-
sity lipoprotein cholesterol, COR serum cortisol
Cardiovascular risk factors SHS score “high”, 
mean ± SD
SHS score “low”, 
mean ± SD
T test P valuea
SBP (mmHg) 119.43 ± 13.27 115.31 ± 13.19 8.573  < 0.001
DBP (mmHg) 77.57 ± 7.38 75.38 ± 7.89 7.880  < 0.001
GLU (mmol/L) 5.23 ± 0.57 5.17 ± 0.55 2.941  < 0.001
TCH (mmol/L) 4.48 ± 0.76 4.32 ± 0.78 5.708  < 0.001
TG (mmol/L) 1.17 ± 0.58 1.08 ± 0.46 4.709  < 0.001
HDLC (mmol/L) 1.32 ± 0.32 1.36 ± 0.36 -3.230  < 0.001
LDLC (mmol/L) 2.82 ± 0.70 2.78 ± 0.71 1.558 0.119
COR (ng/ml) 204.31 ± 40.06 161.33 ± 27.83 34.076  < 0.001
BMI (kg/m2) 23.24 ± 3.76 22.01 ± 3.52 9.268  < 0.001
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tool has been verified in various populations and used as 
an auxiliary tool to screen high-risk groups. For example, 
a SHSQ-25 survey showed that SHS was an independent 
risk factor for T2DM [25] and it can also be used as an 
auxiliary screening tool to explore the comprehensive risk 
factors of cardiovascular disease [24].
Therefore SHSQ-25 provides a window of opportunity 
for early detection and intervention of diseases, and helps 
to reduce the burden of diseases [21]. Except SHSQ-25, 
there are other SHS measures tools available in Chinese 
language, which are mainly used in Traditional Chinese 
Medicine (TCM) practices, e.g., Sub-health Self-rating 
Scale (SSS) has been invented for student SHS measure 
[64]. SSS consists of three symptom dimensions, with ten 
factors supported by 58 items.
Objective measures for SHS
Biochemical and molecular biological tests are of great sig-
nificance for evaluating health status and predicting disease 
progression. Due to the complexity and diversity of SHS 
symptoms, there is no accurate and unified index system 
for biochemical assessment of suboptimal health, but some 
achievements have been obtained in related studies mainly 
involving laboratory examination and related animal experi-
ments [65].
General biological and biochemical indexes
Systolic blood pressure, diastolic blood pressure, total cho-
lesterol, and high-density lipoprotein cholesterol were fund 
Table 3  Suboptimal Health Status Questionnaire-25 (SHSQ-25); 
these questions inquire about health events occurring during the past 
3 months. Every question is required to be marked with an “x” in the 
appropriate box; then, the scores are totalled for a SHS score (Yang 
et al. 2009; Wang and Yan 2012)




Occasionally Often Very often Always
1. Were exhausted without greatly increasing your physical activity?
2. Experienced fatigue that could not be substantially alleviated by rest?
3. Were lethargic when working?
4. Suffered from headaches?
5. Suffered from dizziness?
6. Eyes ached or were tired?
7. Suffered from a sore throat?
8. Muscles or joints felt stiff?
9. Have pain in your shoulder/neck/waist?
10. Have a heavy feeling in your legs when walking?
11. Felt out of breath while sitting still?
12. Suffered from chest congestion?
13. Were bothered by heart palpitations?
14. Appetite was poor?
15. Suffered from heartburn?
16. Suffered from nausea?
17. Could not tolerate cold environments?
18. Had difficulty falling asleep?
19. Had trouble with waking up during night? i.e., kept waking up at night
20. Had trouble with your short-term memory?
21. Could not respond quickly?
22. Had difficulty concentrating?
23. Were distracted for no reason?
24. Felt nervous or jittery?




to be associated with SHS [18]. In addition, plasma glucose 
was associated with SHS in men, and triglyceride in women 
respectively [18]. The SHS group had higher serum cortisol 
than that of health groups and there was a significant linear 
correlation between the SHS scores and serum cortisol level 
[18].
Combined with a stress test tool, Copenhagen Psychoso-
cial Questionnaire (COPSOQ), and further integrated with 
the analysis of the expression of glucocorticoid receptor 
mRNA (GR mRNA), SHSQ-25 proved to be a tool to assess 
chronic psychosocial stress. Plasma cortisol and glucocor-
ticoid receptors are important physiological mediators of 
psychological stress [66]. Plasma cortisol was significantly 
increased in subjects with high SHS scores and the expres-
sion of GR mRNA in peripheral blood monocytes was sig-
nificantly decreased [66]. Another study also confirmed the 
unique value of plasma cortisol in the assessment of SHS 
[67].
A study in Ghanaian women showed that oxidative stress 
is closely related to SHS, and endothelial dysfunction, indi-
cating that a complication of oxidative stress, may also 
have a certain correlation with SHS [32]. Another popu-
lation based study in Russia, which combined measure of 
endothelial dysfunction with the SHSQ-25 to assess car-
diovascular suboptimal health, demonstrated a significant 
association between endothelial dysfunction and suboptimal 
health [24]. The group with high SHS score showed the sig-
nificantly higher levels of systolic blood pressures (SBP), 
diastolic blood pressures (DBP), body mass index (BMI), 
smoking index, total cholesterol (TCH), triglycerides (TG), 
and low-density lipoprotein (LDL) cholesterol [24]. Integra-
tion of suboptimal health status and endothelial dysfunction 
provides a novel tool to allow people to get a more holistic 
picture of both subjective and objective health measures and 
also can be applied to routine screening for risks of cardio-
vascular diseases [24]. Recently the SHSQ-25 tool has been 
adapted as African version of SHSQ-25 from the African 
context [68].
Molecular biological measures
As SHS is the transition stage from health to disease, the 
study on the quantitative change from the perspectives 
of proteomics, glycogenomics, metabolomics and tel-
omere length might provide another point of view for SHS 
pathogenesis.
Proteomic studies showed that many SHS people have 
immune abnormalities, involved in cytokines-mediated 
immune responses with inflammatory consequence. A con-
trolled study in Japanese population found that mRNA levels 
and production of transforming growth factor-beta1 (TGF-
β1) were significantly reduced in people with chronic fatigue 
syndrome (CFS) [69]. The lack of cytokine in CFS may lead 
to myalgia and muscle fatigue.
SHS is a contributing risk factor for metabolic syndrome. 
N-glycan is associated with metabolic syndrome, according 
to suboptimal health and glycosomics studies conducted in 
Ghanaian population [70]. Four glycan peaks (GPs), GP8 
(FA2[6]G1), GP18 (FA2G2S1), GP21(FA2G2S2), and 
GP34 (A4G4S[3,3,6,]3), were found to predict sub-health 
and metabolic syndrome status (70). Figure 3 highlights gly-
comics as the SHS diagnostic tool.
Metabolomics studies have demonstrated that chronic 
fatigue syndrome is a highly coordinated hypometabolic 
response, identifying metabolomics as a powerful tool for 
identifying chemical differences between health and disease 
[71]. A combination of four metabolic biomarkers (sphingo-
sine, pregnanolone, taurolithocholate sulfate, cervonyl carni-
tine) is able to distinguish SHS individuals from the controls 
with a sensitivity of 94%, a specificity of 90%, and an area 
under the receiver operating characteristic curve of 0.977 
[72]. SHS-related metabolic disturbances can be detected at 
the early stage and SHS-related metabolites creates a win-
dow of opportunity for chronic diseases management from 
the perspective of PPPM [72].
In addition, there were studies reporting that women had 
a higher collagen/non-myofibromyin turnover in the amino 
acid composition of urine, indicating diverse characteristics 
of the urinary excretion of amino acids in humans and sug-
gesting the use of amino acid supplementation to reduce 
fatigue and suboptimal health in adults [73].
Besides of these molecular biological measures, a study 
measuring relative telomere length (RTL) found that SHS 
was significantly associated with short RTL, indicating com-
bination of subjective (SHS) and objective (RTL) measures 
is a novel tool for accelerated ageing investigation [63].
The outlook of SHS diagnostic tools
Previous studies have proved that SHSQ-25 has a wide range 
of applicability. It is an inevitable task to translate SHSQ-
25 into other diverse languages. Currently, there are three 
languages versions of SHSQ-25, Chinese, English and Rus-
sian. We need more effort to translate SHSQ-25 into more 
local languages to apply it amongst different ethnic groups.
In animal models for SHS mechanism study, although 
some animals, such as rat and mice, have been experimented 
to simulate the physiological and psychological negative sta-
tus of human SHS, they cannot be completely equivalent to 
human [74, 75]. Animal study will improve our knowledge 
on SHS mechanism.
The existing SHS assessment criteria and the thresh-
olds are based on the cut off values which do not meet 
the ranges for clinical disease diagnosis, and the range 
value is narrow, so a single or a few indicators are often 
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difficult to truly reflect the SHS of an individual. In this 
regard, the reliability and validity of diagnosis may be 
greatly improved by using large sample investigation or 
experiment, screening the combination of physiological 
and biochemical indicators, and constructing the detection 
index spectrum of different subtypes of SHS.
The research on molecular biology of SHS has made 
achievement, but it has been mainly limited to laboratory 
detection, lacking convenient, fast, sensitive, efficient and 
low-cost practical detection tools [66, 67]. The develop-
ment of high-through-put, standardised and practical bio-
logical detection chips or kits will be the main direction of 
diagnosis or screening. For example, N-glycans are crucial 
for intra/extracellular interaction or signalling, cell adhe-
sion, translocation, cell–cell or molecule-cell interaction, 
inflammation and immune function and they are dynamic 
biomarkers for monitoring physiological conditions. The 
advanced glycomics detection measurement will become 
a powerful objective measure to evaluate SHS [76, 77].
The future SHS research must follow a comprehensive, 
large sample, qualitative and quantitative paradigm. This 
will produce a huge amount of data, coupled with the mas-
sive bioinformatics data generated by molecular biology 
technology, and the demand for data processing and analy-
sis will become more and more prominent. In future, more 
effective data analysis and mining measures and artificial 
intelligence will not be absent.
Suboptimal health status, risk factors 
and risk group
Suboptimal health status (SHS) has several adverse out-
comes due to physical, psychological, and social stress of 
an individual [21]. However, its main underlying mechanism 
is still unclear [78]. As a result of physical and psychologi-
cal changes, the overall coordination of the body system 
becomes imbalance and dysfunction (the nervous system, 
Fig. 3  The 24 IgG glycan peaks as measured with ultra-performance 
liquid chromatography (71). Shown are the structure of the main IgG 
glycan component(s) per peak and their structure abbreviation. Struc-
ture abbreviations: F, α-1,6-linked core fucose; A, number of anten-
na's attached to the core sequence (existing of two N-Acetylglucosa-
mine (GlcNAc) and three mannose residues); B, bisecting GlcNac 
β1–4 linked to β1–3 mannose; M, number of mannose residues; G, 
number of β1–4 linked galactoses; [3] G1, galactose on the antenna 
of the α1–3 linked mannose; [6] G1, galactose on the antenna of the 
α1–6 linked mannose; S, sialic acid linked to galactose. Structural 
schemes are defined as follows: blue square, GlcNac; green circle, 
mannose; red triangle, core fucose; yellow circle, galactose; and pur-
ple rhomb, sialic acid
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endocrine system, and immune system), these lead to decline 
of physiological, psychological and social functions; how-
ever, the body has not yet moved to the disease stage [20, 
78, 79].
“People with SHS face different chronic conditions, such 
as chronic fatigue, headache, dizziness, depression, anxiety, 
loss of appetite, insomnia and functional disorders” [27]. 
Similarly, several organ systems, non-specific pain, func-
tional disorders of different organ systems (the digestive 
system, cardiovascular system, respiratory system, urinary 
system) are associated with short-term or long-term adverse 
health outcomes [80]. For example, SHS plays a vital role 
in impairing the quality of life, resulting in frequent hospi-
tal visits and significant medical expenses. Still, no obvi-
ous symptoms of any particular disease appear, making the 
victims frustrated thus disabling their normal life [27, 78].
The prevalence of SHS is high in China [79], and consist-
ently it has been growing in other countries. SHS's symp-
toms might be underestimated everywhere, and many indi-
viduals do not know about suffering from SHS [27]. For 
example, a study conducted in China with 6000 healthy 
people found that about 72% of participants had SHS [79]. 
Therefore, many scientists worldwide have focused on age, 
gender, occupation, geographic region, and behaviour of per-
sons at high risk of having SHS in recent days. A personal 
health monitoring mechanism is required to prevent SHS 
and chronic disease. To focus on the above issue, recently 
introduced PPPM (predictive, preventive, and personalised 
medicine), a new paradigm of public health services tech-
nique intensively expanded worldwide [81, 82].
Relationship between chronic diseases and SHS
According to WHO [83], non-communicable diseases 
(NCDs), also called chronic diseases, kills 41 million peo-
ple per year globally. Likewise, more than 15 million peo-
ple die each year from NCD age between 30 and 69 years 
old (a productive age group), and these premature deaths 
occur mainly in low- and middle-income countries (LMICs), 
which is 77% of all NCD death (84). In addition, alone cardi-
ovascular diseases (heart attacks and stroke) kill about 17.9 
million people, followed by 9.3% cancer, 4.1 million by res-
piratory conditions such as chronic obstructive pulmonary 
diseases (COPD), and 1.5 million people with diabetes per 
year around the world. Notably, these four diseases record 
more than 80% of premature deaths by NCD [83].
Curiously, WHO again stated that tobacco use, physi-
cal inactivity, alcohol use, and unhealthy diets are the risk 
factors to increase NCD deaths. Similarly, children, adults, 
and the older adults are more vulnerable to the risk factors 
contributing to NCDs, that may be due to above risk factors 
[83].
On the other hand, SHS is regarded as a subclinical 
reversible stage of chronic diseases and has been found a 
potential risk factor for chronic conditions, e.g., diabetes 
mellitus, cardiovascular and stroke, including several can-
cers and metabolic diseases [20, 80]. Many evidences show 
that an individual’s modifiable behaviour, such as smoking, 
insufficient physical activities, unfit eating habits, and exces-
sive alcohol intake, are the risk factors for NCDs [83, 85, 
86]. About 7.2 million people deaths each year by tobacco 
use, following 4.1 million deaths by high salt intake, 3.3 
million people by alcohol use associated with cancer, and 
1.6 million deaths due to physical exercise [84]. Therefore, 
WHO has made a target to reduce premature deaths from 
NCDs through a sustainable development agenda by 2030 
[87].
There are numerous risk factors for the occurrence of 
chronic diseases, e.g., socio-economic status, education 
level, daily physical exercise, salt intake, blood pressure, car-
diovascular markers, triglycerides, cholesterol, alcohol use, 
and a poor eating habit [21, 78, 86]. Many studies suggested 
that cigarette use, physical inactivity, unbalanced diet, insuf-
ficient sleep, and uncontrolled blood pressure are directly 
associated with SHS risk [27, 29, 78, 80, 88]. Similarly, 
these risk factors are associated with a lifestyle or behaviour 
of a person, and these unhealthy lifestyles or behaviour play 
a significant role in increasing the SHS [78, 88, 89].
Lifestyle factors and SHS
A study found that lifestyle factors have a stronger indirect 
association with physical, mental, and social SHS by health 
consciousness than direct physical, mental, and social SHS 
associations [79]. This study also established that health 
consciousness has a strong direct relationship with physi-
cal, mental, and social SHS [90]. However, many studies 
have been recognised that lifestyle factors are important risk 
factors for SHS [27, 91]; those include smoke habits, alco-
hol use, skipping breakfast, dietary inconsistency, exercise 
deficiency, and sleep problems [27, 91, 92]. Consistently, 
SHS is associated with risk factors of chronic diseases and 
subsidised to developing these diseases [93] Therefore, eve-
ryone can be prevented from chronic diseases by modifying 
their poor lifestyle behaviours.
A healthy lifestyle includes a multidimensional pattern 
of self-initiated perceptions and activities to maintain and 
improve individual’s health and wellbeing [91, 93]. These 
kinds of perceptions and activities can reduce the occur-
rence of the disease, decrease the death rate and contribute 
to improving health status. On the other hand, risky health 
behaviours play a significant role in increasing the risk for 
injury and disease conditions [85], such as tobacco and 
alcohol use, a poor diet habit, and lack of body activities, 
which lead to various chronic diseases. The WHO has also 
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emphasised that unhealthy behaviour and lifestyle are impor-
tant factors amongst the top ten causes of death worldwide 
[94–97].
Adolescent period and SHS
Adolescent age (10 to 24 years) is a crucial age, transition-
ing between childhood and adulthood [98]. This period is 
characterised by pubertal maturation, the transition towards 
the mature for adulthood’s social roles and developing inde-
pendence [99]. Therefore, it is also called a time of “Storm 
and Stress” [100, 101]. Especially, the preadolescent period 
poses a unique opportunity to affect family health behaviours 
before the child becomes more peer-focused. In addition, 
to develop confidence ability to be physically active (self-
efficacy), the idea about the consequences of being physi-
cally active (beliefs) and influences of family and friends 
on physical activities (social influences) affect the physical 
activity of adolescents [102]. The adolescent is an intensi-
fied influencing time to expose with peer group and adopt 
unhealthy behaviour such as alcohol use, smoking habit, 
unhealthy diet etc. [99]. These consequences affect both cur-
rent and future health status; however, the adolescent period 
also provides considerable opportunity for behaviour to be 
shaped in a positive way that may improve long-term health 
outcomes [99].
Epidemiological data showed that risk behaviours are the 
leading cause of adolescent morbidity and mortality glob-
ally [95]. The risk behaviour reaches a peak in adolescence, 
signifying that this period demonstrates a high propensity or 
inherent tendency to take risks [97]. Because of their high-
risk taking tendency, they often suffer accidents or injuries 
[103]. This type of risk-taking behaviour during adolescence 
always puts them at risk [101].
During the adolescent period, several changes occur, 
such as physical development, reproductive health develop-
ment, mental health, social and emotional changes. Lifestyle 
behaviours during youth are the foremost important period 
of life. That is why adulthood is an important age for form-
ing healthy behaviour or poor behaviour, and those factors 
are associated with an increase in the risk of chronic diseases 
[104]. Though, unhealthy practices and behaviour, along 
with poor lifestyles of young ages, may be a pathway to a 
whole lifespan, determining the increased cause of health 
risk in old age [91]. Unhealthy behaviour during adolescence 
can play a vital role in developing health consequences in 
later life [105].
Likewise, students’ risky behaviour during their college 
or university life is also a crucial part of increasing diseases 
appearance in the second part of their life [106]. The study 
showed that SHS was high in high school students, where 
the detection rate of physical SHS and Psychological SHS 
was elevated [78]. The physical and mental development 
during adolescent age may be an ideal time to know the 
health information. This information would be a piece of 
evidence to understand the level of health status. Thus, the 
health assessment information during the college or univer-
sity period can be the more convincing evidence to prevent 
chronic disease for the future age [78].
It has been acknowledged that SHS can be prevented if 
it is diagnosed in the early stage and starts timely manage-
ment. Therefore, a new treatment paradigm or mechanism is 
originated to enable people for early intervention of disease 
in terms of PPPM [80–82].
Individualised preventive measures
The natural history of a disease stages includes: underlying, 
susceptible, subclinical, clinical, and recovery/disability/
death [107]. Correspondingly, according to the WHO guide-
lines, health prevention have been grouped into primary, sec-
ondary, and tertiary prevention [108]. The combination of 
these preventive measures can prevent the onset of disease 
through risk reduction, and also the downstream complica-
tions of manifested diseases [107].
Individualised disease prevention
Primary prevention refers to measures aimed to avoid the 
manifestation of a disease at both individual and population 
levels [109]; therefore, its target population is the healthy 
individuals [107, 110]. It commonly institutes actions that 
prevent from exposures to hazards, increase immunity, miti-
gate disease risk, alter unhealthy behaviours, or supply nutri-
tion and food to prevent disease progress from a susceptible 
individual to the subclinical stage of disease [108].
Secondary prevention emphasises early detection, which 
improves the chances for positive health outcomes [108]. 
Secondary prevention targets healthy-appearing individuals 
in the subclinical stage of the disease [107]. The subclinical 
disease is regarded as the initial period of a disease with no 
recognisable symptoms [111]. The main form of secondary 
prevention is evidence-based screening programs imple-
mented at the early stage of a disease [109, 110].
Tertiary prevention is administered in symptomatic 
patients [108]. It aims to reduce effects of the ongoing dis-
ease on individuals, commonly by treating disease, provid-
ing rehabilitation, eliminating disability, screening com-
plications, halting disease progression, restoring function, 
minimising suffering, and maximising potential years of 
quality life [112–114]. However, the intervention is by no 
means a cure, and close follow-up of chronic disease are 
required including supervising medications taking, moni-
toring changes, and supporting patients to maximise the 
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capacity to live independently in daily life is an essential 
element of public health [114].
Individualised prevention, which may also be referred to 
as personalised prevention, predictive, stratified prevention, 
is an attempt to refocus attention to preventing disease at 
the level of the individual [115, 116]. Biological variation 
plays a major role in individualised prevention because the 
most accurate and effective prevention for an individual is 
based on individuals’ health status, his or her unique genetic, 
environmental and behavioural factors [116, 117]. Form 
the perspectives of predictive, preventive and personalised 
application, the current clinical applications involve the 
use of subjective and objective measurements. Subjective 
measurements are dependent on observers’ opinions, feel-
ings, and general impressions, and self-report questionnaires 
are the main types of assessment approach. For example, 
Suboptimal Health Status Questionnaire-25 (SHSQ-25), a 
reliable, valid, and robust and targeted health measure tool, 
is applied to assess Suboptimal Health Status (SHS). “The 
concept of SHS, an intermediate and reversible physical 
state between health and disease, illuminate the viewpoint 
that non-communicable chronic diseases can be effectively 
predicted and prevented before the occurrence of a clinical 
manifestation of severe pathologies” [1, 21, 118]. Objective 
measurements are impartial, usually quantifiable outcomes 
recorded, and one of most common approach to quantify-
ing objective outcomes is the measures of biomarkers, such 
as C-reactive protein (CRP), interleukin-6 (IL-6), tumour 
necrosis factor alpha (TNF-α), DNA methylation, and immu-
noglobulin G (IgG) N-glycan profiling. Glycosylation, a 
common co- and post-translational modification of IgGs, 
mediate anti-inflammatory and pro-inflammatory responses 
through affecting the IgGs’ folding, structure, stability and 
effector functions. Identifying biological mediators of SHS 
will not only help with effective interventions to reverse 
SHS, but clarify the mechanisms between SHS and SHS-
related chronic disease. Glycosylation of IgG is an important 
regulator of the immune responses and changes in glycan 
structures may provide information about the mechanisms 
of SHS and the etiological link between SHS and chronic 
disease, such as metabolic syndrome (MetS) [119], cancer 
[120], Parkinson’s disease [121, 122], systemic lupus ery-
thematosus (SLE) [123], rheumatoid arthritis (RA) [124], 
dyslipidemia [125], hypertension [126], cardiovascular dis-
eases [24], type 2 diabetes mellitus (T2DM) [127], stroke 
[126], and ageing [128], that can then provide strategies for 
the a reversal of SHS.
In practical terms, the individualised prevention not only 
aims to replace existing classic, population or community-
based public health efforts, but to ensure individuals can 
access the right prevention with accurate dose and at the 
proper time to optimise the benefit-risk ratio of all inter-
ventions maximising efficacy and safety [129]. Hence, both 
primary and secondary prevention can be precisely applied, 
providing cost-effective and tailored preventive strategies for 
the reversal of SHS [117, 129].
Preventions for established objective measurement 
of SHS
From the perspective of PPPM, the concept of SHS reflects 
“the viewpoint that chronic diseases can be effectively pre-
dicted and prevented before the occurrence of a clinical 
manifestation of severe pathologies” [11]. Consequently, the 
early identification of SHS has the potential to predict and 
prevent NCDs at the early stages, and effective prevention on 
SHS may be a cost-effective way for preventing NCDs [118]. 
In order to fast and cost-effectively evaluate SHS, and in line 
with PPPM, we developed “the innovative, reliable, valid 
and robust health measure tool, Suboptimal Health Status 
Questionnaire-25 (SHSQ-25)” [27].
The key principle of disease prevention (Fig. 4) is to 
apply PPPM strategies to prevent the development of the dis-
ease at the onset of SHS. Ideally, intervention should occur 
at the point where there are relevant symptoms deviating 
away from health, yet do not meet the standard diagnostic 
criteria of a diagnosable disease. To prevent SHS, we should 
pay attention not only to the physical health status when 
non-recognisable symptoms of diseases approach, but also 
to the emotional and mental status. It is necessary to apply 
preventive strategies by the person-tailored intervention 
approaches to provide cost-effective and tailored preventive 
measures based on the integrative concept PPPM. Here, we 
present case studies to prove the effectiveness of preventive 
measures on SHS.
Case study one: Intervention effect of Baduanjin exercise 
in people with SHS
Growing evidence continues to prove that regular exercise 
or physical activity can contribute to improve physical and 
psychological health conditions [130]. Moreover, traditional 
Chinese exercises, such as Baduanjin exercise, are effective 
exercise programs for enhancing health promotion in body 
composition, physical fitness, and mental health [131–133]. 
Baduanjin exercise consists of eight separate, delicate, and 
smooth exercise movements: each movement brings certain 
function-enhancing benefits to particular parts or organs in 
the body (Fig. 5) [134].
To evaluate the effect of Baduanjin exercise on fatigue 
in people with SHS, a clinical trial was conducted. A total 
of 131 participants was recruited and allocated into the 
Baduanjin group (n = 64) and the control group (n = 67) 
[135]. After intervention, participants were followed up for 
12 weeks to assess the sustained effect of Baduanjin exer-
cise on SHS. Statistical analyses were conducted to compare 
the SHS score at different time points, including baseline, 
4th and 6th week after the intervention, and 12th and 18th 
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week during the post-intervention follow-ups. The results 
showed SHS scores were significantly decreased (P < 0.05) 
(see Fig. 6).
Case study two: Effectiveness of mild moxibustion for 
SHS in pre- and post-menopausal women
Due to dysregulated endocrine functions, peri-menopausal 
women often suffer from SHS with discomfort symptoms, 
including fatigue, insomnia, hot flushes, irritability, men-
tal confusion, headache, and difficulty concentrating [136]. 
Moxibustion, a form of heat therapy in which dried plant 
materials called “moxa” are burned on acupoints, has been 
reported as a clinical treatment method and for self-care at 
home amongst Chinese and other Asian people [137]. To 
investigate the efficacy and safety of using mild moxibustion 
for treating SHS in peri-menopausal women, a randomised 
controlled trial (RCT) was conducted in 60 participants ran-
domly assigned to the moxibustion and control groups. The 
moxibustion group received mild moxibustion and the con-
trol group gained vitamin E soft capsules [138]. The results 
showed SHS significantly improved in the moxibustion group 
Fig. 4  Individualised prevention 
strategies. Primary prevention 
includes individuals with no 
disease who receive preventive 
measures. Secondary prevention 
is screening to detect subclini-
cal stages of diseases. Tertiary 
prevention is management of 
disease. SHS, suboptimal health 
status
Fig. 5  Standardised Baduanjin 
exercise by the Chinese Health 
Qigong Association (134). 
Each of the displayed move-
ment brings certain function-
enhancing benefits to particular 
parts of the body. A Prop up the 
sky with hands to regulate the 
triple energiser. B Draw a bow 
on both sides like shooting a 
vulture. C Raise single arm to 
regulate the spleen and stomach. 
D Look back to treat five strains 
and seven impairments. E Sway 
head and buttocks to expel heart 
fire. F Pull toes with both hands 
to reinforce the kidney and 
waist. G Clench fists and look 
with eyes wide open to enhance 
strength and stamina. H Rise 




compared with the control group (P < 0.01). Compared to 
post-menopausal women, pre-menopausal women showed 
more prominent improvements in SHS (P < 0.05). In addi-
tion, there was a significantly higher estradiol (E2) levels in 
the moxibustion group than the control group after treatment 
(P < 0.01), and pre-menopausal women had higher E2 levels 
in the moxibustion group when compared to post-menopau-
sal women (P < 0.01). In comparisons of pre- and post-men-
opausal women, pre-menopausal women had significantly 
higher levels of E2 (P < 0.01), prolactin (PBL; P < 0.05) and 
progesterone (P < 0.01), while levels of luteinising hormone 
(LH) and follicle-stimulating hormone (FSH) were signifi-
cantly higher in post-menopausal women (P < 0.01).
Case study three: Effects of pulsatile cupping on body 
pain and quality of life in people with SHS
Cupping therapy is an ancient medical technique, and 
it applies heated cups on the skin to remove stagnation 
and stimulate the flow of “Qi” [139]. Due to its non-
invasive simple operation and rapid effects, cupping has 
been broadly used in China and other Asian population 
[140]. In clinical practice, cupping has been reported as a 
main clinical treatment method to relief SHS and increase 
patients’ general feeling of wellbeing [141].
A four-arm, randomised clinical trial was conducted to 
investigate effects of the pulsating frequency of pneumatic 
pulsatile cupping, compared with traditional cupping, on 
body pain and quality of life in people with SHS [142]. 
This study recruited 96 SHS participants randomised to 
low-frequency (LF) or high-frequency (HF) pulsating 
cupping (see Fig. 7), traditional cupping (TC) or wait-list 
(WL) groups.
After treatment, the symptom of pain was significantly 
reduced in LF and HF groups when compared to TC group 
(PLF = 0.048; PHF = 0.004), respectively; and the quality 
of life was significantly improved in LF and HF groups 
(PLF = 0.046; PHF = 0.004). Moreover, in comparisons of 
the WL group, the symptom of pain significantly reduced 
(both P < 0.0001) whilst the quality of life significantly 
improved (both P < 0.0001) in LF and HF groups. How-
ever, there was no significant difference between LF and 
HF groups (P > 0.05).
Fig. 6  Trends in changes in the scores for SHS [50]. SHS, suboptimal 
health status
Fig. 7  Pulsating cupping devices, the figure is adapted from (142). A 
One tube connects with a Bian-stone cup. In the bottom of the Bian-
stone cup, a micro-camera is set and connected wirelessly to a com-
puter to monitor colour changes in the cup. B One tube connects with 
an acrylic cup to show the vibrations at various frequencies. C Sche-
matic diagram of the device shows complex stimulation (vacuum and 
vibration) performed on the local tissues of the skin. min, minutes
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Preventions‑established objective measurement 
of SHS
When health deteriorates (i.e., in SHS) the molecular pro-
cesses are already perturbed in a measurable way, but there 
is still no condition that meets the clinical diagnostic crite-
ria of disease. At molecular level, immunoglobulin G (IgG) 
glycosylation plays a critical role in inflammation process 
(70); thus, glycans are conceived as one of the ideal objec-
tive biomarkers for measuring SHS.
The IgG, linking the innate and adaptive branches of the 
immune system, is one of the most extensively characterised 
glycoproteins overall [143]. The effector’s functions of IgG 
are modulated via fragment crystallisable (Fc) N-glycans 
[144]. In addition to directly affecting conformation of the 
fragment crystallisable (Fc) region, conserved N-glycans 
attached to the constant heavy 2 (CH2) domain of the IgG 
Fc region also mediate downstream immune responses 
(i.e., anti-inflammatory or pro-inflammatory responses; 
see Fig. 8) [121, 145]. Additionally, variations to the IgG 
N-glycans can elicit ageing at the molecular level through 
a process generalised as inflammageing [146]. Since IgG 
N-glycans are valuable biomarkers for SHS identification 
and create a window opportunity for PPPM of SHS, IgG 
N-glycans can be adapted as the molecular parameter for 
individualised monitoring and prevention of SHS.
The epidemics of obesity, physical inactivity and 
unhealthy diet are driving an increase in SHS that is a new 
challenge for both population and individual health. The 
increase in costs with regards to the management of non-
communicable diseases is burdening healthcare budgets 
under increasing strain. Changing the focus towards SHS 
prevention is the only sustainable approach to this problem. 
Since IgG N-glycans can be adapted as a biomarker of SHS 
and its compositions can be modified through interven-
tions, it is possible to monitor effects of beneficial interven-
tions. This enables individualised management of lifestyles, 
thereby minimising the risk of SHS from the perspectives 
of PPPM.
Case study one: Intense physical exercise induces an anti-
inflammatory change in IgG N-glycosylation profile
To explore effects of intense physical exercise on the IgG 
N-glycome composition, a longitudinal intervention study 
was conducted with 29 males. Samples were measured in 
three time points: pre-intervention, at the peak of the train-
ing program intensity (EXC), and one-month post-inter-
vention (recovery period, REC). After the analysis of IgG 
N-glycosylation, results from the baseline, EXC, and REC 
time points were compared. The following derived glycan 
traits were analysed: agalactosylation, monogalactosylation, 
digalactosylation, monosialylation, disialylation, bisection, 
and core fucosylation. Estimated effects of exercise showed 
significant differences in IgG N-glycans in the REC time 
point compared to the baseline (Table 4): agalactosylated 
N-glycans decreased (− 0.8080, P = 0.0473), and both 
digalactosylated and monosialylated N-glycans increased 
(0.9949, P = 0.0473 and 0.5270, P = 0.0339, respectively) 
[147].
Case study two: Effects of estradiol on biological age 
measured using the glycan age index
To evaluate the effects of ovarian sex hormone suppres-
sion followed by estradiol supplementation on biological 
age (measured by the glycan age), a double-blinded ran-
domised controlled trial (RCT) was conducted based on 
Fig. 8  Immunoglobulin G effector functions are modulated by Fc-bound N-glycans, the figure is adapted from. GlcNAc, N-acetylglucosamine; 
ADCC, antibody-dependent cellular cytotoxicity; FcyRIIB, Fc gamma receptor type IIB; MBL, mannose binding lectin
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a parental trial [148]. A total of 36 healthy young women 
were included in this study. All underwent suppression of 
ovarian gonadal hormones with gonadotropin releasing 
hormone agonist therapy (GnRHAG) for a period of five 
months. Meanwhile, participants were randomly allocated 
into estradiol (E2) intervention (GnRHAG + E2, n = 15) and 
placebo control group (GnRHAG + PL, n = 21). Inclusion 
and exclusion criteria, as well as protocol of the study can 
be obtained from the parent trial [149].
IgG N-glycans were measured at three time points: pre-
intervention, post-intervention and after subsequent recovery 
(see Fig. 9). GlycanAge expressed in years was calculated 
using the following formula:
Glycan age = 56.08 + 776.01 × GP6 − 5376.83 (GP6)2 − 
215.10 × GP14 − 30.70 × GP15.
where GP < n > is nth peak in chromatogram expressed 
as the proportion of total chromatogram area [150]. 
Suppression of gonadal hormones resulted in a significant 
increase in glycan age by 9.1 years; however, glycan age 
was significantly prevented by estradiol therapy (change in 
glycan age =  − 0.23 years). After the recovery period, glycan 
age returned to baseline values in both groups.
Case study three: Extensive weight loss reduces glycan 
age by altering IgG N-glycosylation
Bariatric surgery is a considerably effective treatment 
for severe obesity [151]. To investigate whether weight loss 
can affect GlycanAge related to inflammation and ageing, 
an exploratory cohort recruited 37 obese participants from 
Oxford University Hospitals to the Gastrointestinal Illnesses 
study, and a replication cohort included 2146 participants 
from the TwinsUK study. In the exploratory cohort, partici-
pants were subjected to 3-week low-calorie diet, followed by 
bariatric surgery. The IgG N-glycans were chromatographi-
cally profiled at baseline, the day of the surgery, and the day 
Table 4  Estimated effects of training intervention on levels of individual derived IgG N-glycan traits, and their respective unadjusted and 
adjusted P-values (147)
The exercise effect coefficients are calculated relative to the baseline. Significant results are shown in bold. EXC exercise intervention, Adj. 
adjusted, REC recovery period. Decreased agalactosylated N-glycans and rise in digalactosylated and monosialylated N-glycans attached to IgG 
suggest intense physical exercise indeed induced anti-inflammatory effects
Structural feature Estimate EXC P-value EXC Adj. P-value EXC Estimate REC P-value REC Adj. P-value REC
Agalactosylation  − 0.2009 0.5394 0.6152  − 0.8080 0.0190 0.0473
Monogalactosylation  − 0.1040 0.5388 0.6152  − 0.1710 0.3149 0.4409
Digalactosylation 0.3049 0.4554 0.6152 0.9950 0.0203 0.0473
Monosialylation 0.2688 0.1283 0.6152 0.5270 0.0048 0.0339
Disialylation 0.1430 0.2206 0.6152 0.2465 0.0399 0.0698
Bisection 0.0901 0.5807 0.6152 0.1095 0.5030 0.5868
Core fucosylation  − 0.0373 0.6152 0.6152  − 0.0339 0.6479 0.6479





of 20% of weight loss. After glycan data quality control, 
plasma-derived IgG N-glycan traits of 3742 samples with 
body mass index (BMI) information were longitudinally 
monitored in the replication cohort [152].
The results showed that the levels of IgG bisecting Glc-
NAc were significantly decreased (− 0.2801, P = 0.0341) 
after the low-calorie diet intervention, indicating a decreased 
pro-inflammatory potential of the circulating IgG. Statistical 
analysis revealed extensive alterations in IgG N-glycome 
following the bariatric surgery during 1-year follow-up. 
Four tested derived traits were observed marked changes: a 
significant increase in digalactosylated (0.0275, P = 0.0015) 
and sialylated (0.0193, P = 0.0394) glycans, and a substan-
tial decrease in agalactosylated (− 0.0339, P < 0.001) and 
core fucosylated (− 0.0155, P = 0.0394) IgG N-glycans. Loss 
of BMI over a 20-year period in the TwinsUK cohort vali-
dated a weight loss-associated increase in the abundance of 
digalactosylated (0.2004, P < 0.001) glycans and decrease 
in the abundance of agalactosylated (− 0.1048, P = 0.0179) 
and high mannose (− 0.0519, P < 0.001) glycans.
In conclusion, individualised SHS assessments are the 
reliable and robust platform for successful preventive strat-
egies. Thus, individualised preventive measures for SHS 
should be based on the established SHS measurements, 
including SHSQ-25 and IgG N-glycans profiling. The exam-
ples of targeted preventive measures, as reviewed above, 
demonstrated positive effects on the health improvement 
by applying a combination of subjective and objective SHS 
measurements. It offered a comprehensive strategy for the 
individualised preventing from SHS moving into disease 
phase, from the perspectives of PPPM.
Treatment algorithm tailored to individual 
at risk of non‑communicable diseases
The innovative PPPM, as the central part of efforts in health-
care management, is aimed at reducing the incidence and 
prevalence of several non-communicable diseases such as 
diabetes mellitus, preeclampsia, cardiovascular diseases, 
mental disorders, malignancies, dental and other patholo-
gies via the SHS concept as one of its pillars.
Treatment algorithm tailored to individual at risk 
of T2DM
PPPM holds the key to transforming diabetes mellitus care 
by promoting adequate patient stratification and predic-
tion of adverse drug-drug interaction [13, 153–155]. Taken 
together, this led to better health outcomes, delayed the 
onset of complications, improved quality of life and pro-
moted healthy longevity. As with many chronic diseases, 
screening for prediabetes is central in PPPM, and it provides 
the stimulus for initiating treatment and delaying long-term 
complications and development of diabetes mellitus. SHS 
is found to be an independent risk factor for type 2 diabetics 
mellitus (T2DM), which was accompanied by abnormal bio-
chemical levels and poor lifestyle modifications [25, 26]. A 
Ghanaian cohort study by Adua et al. [25] primarily seden-
tary (2.97-fold increase), high systolic blood pressure (1.86-
fold increase), diastolic blood pressure (2.39-fold increase), 
and high triglyceride concentration were found to be inde-
pendent risk factors of SHS. Another cohort by Ge and col-
leagues amongst a Chinese population the fourth, third, and 
second quartile SHS scores were found to be associated with 
a 1.7-fold, 1.6-fold, and 1.5-fold risk of developing T2DM, 
respectively when compared with the lowest quartile of SHS 
scores [26]. In the latter study, SHS yielded an area under 
the curve (AUC) of 0.848 indicating that SHS screening can 
identify over 80% of prediabetics who may need to be man-
aged. Thus, the management of T2DM is suboptimal; how-
ever, undiagnosed risk factors remain prevalent. Identifying 
SHS individuals at increased risk of poor lifestyle, abnormal 
clinical characteristics, and cardiometabolic factors creates 
an opportunity for clinicians to adopt a nutritional and life-
style modifications tailored towards the high-risk population 
to prevent the onset of T2DM (2). Early detection followed 
by appropriate intervention for SHS individuals is important 
for preventing the onset of T2DM. It is, therefore, incumbent 
for clinicians to shift from the perspective of delayed inter-
vention approach to early screening of individuals for SHS, 
especially prediabetes. Routine SHS screening can be useful 
for the purposes of PPPM.
Treatment algorithm tailored to conditions associated 
with women’s health
Integration of SHS evaluation as a criterion for predic-
tion of preeclampsia has been strongly recommended for 
healthcare management in pregnancy [9]. In a prospective 
cohort study conducted amongst a Ghanaian population, 
SHS identified approximately 89.8% (AUC = 0.898) of 
normotensive pregnant women within their early gestation 
to be at risk of developing preeclampsia (PE) and between 
78.0 and 82.0% for those likely to develop PE coexisting 
with stillbirth, intrauterine growth restriction, haemolysis 
elevated liver enzymes and low platelet count (HELLP) 
syndrome, acute kidney injury, and dyslipidaemia [31]. 
Again, these normotensive pregnant women were found to 
have imbalances in oxidative stress (OS) and angiogenic 
growth mediators (AGMs) at early gestation [10]. Anto 
et al. (32) in their study further found that the first quar-
tile for placental growth factor (2.79-fold increase) and 
vascular endothelial growth factor-A (5.35-fold increase), 
and the fourth quartile for soluble endoglins (4.31-fold 
increase), soluble tyrosine kinase receptor 1 (1.84-fold 
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increase), 8-prostagliandinF2-alpha (2.23-fold increase), 
and 8-hydroxydeoxyguanosine (1.90-fold increase) were 
independently associated with SHS. While these OS 
and AGMs are important factors in placental and foe-
tal development, a high SHS score at early gestation in 
pregnancy is suggestive of increased risk of adverse preg-
nancy outcome and imbalance in biochemical measures, 
which calls for combined antioxidant and proangiogenic 
supplementations tailored towards the high-risk women. 
Evaluation of SHS criterion along with oxidative stress 
and angiogenic growth mediators can create an opportu-
nity for predictive preventive and personalised medical 
care for pregnant women.
Hormonal imbalance, which occurs amongst women 
during their climacteric period, has been linked to vagi-
nal dryness (VD), even though suboptimal health con-
dition has been implicated [156]. Some of factors that 
contribute to VD factors including Flammer syndrome 
(FS) are clearly preventable and, therefore, if managed 
well, have a potential to reduce the risk of VD. Improving 
modifiable risk factors associated with FS phenotype at 
the level of primary prevention and treatment is strongly 
recommended. SHS assessment can create opportunity for 
monitoring and management of women likely to develop 
VD. Thus, future study may screen both pre-and post-
menopausal women for VD using SHS criterion.
Treatment algorithm tailored to individual at risk 
of poor cardiovascular health
Maintaining a higher ideal cardiovascular health (CVH) is 
essential for reducing the risk of cardiovascular diseases 
(CVDs) [23]. In a cross-sectional analysis of a China sub-
optimal health cohort study (COACS), the prevalence of 
SHS was 7.10%, 9.18%, 10.04%, and 10.62% in the first, 
second, third and fourth quartiles of cardiovascular health 
(CVH) metrics [12]. While the development of CVD is 
chronic, early identification of SHS individuals with poor 
CVH metrics such as high blood pressure, high choles-
terol, high glucose, cigarette smoking, obesity, physical 
inactivity and poor dietary habit is an avenue to start per-
sonalised medical care [23]. SHS has not only been found 
to be associated with poor CVH [25, 29] and behavioural 
factors [29, 88], but also combined assessment of SHS 
and index of endothelial function and arterial stiffness, 
independently identified individuals at risk of cardiovas-
cular disease [24]. Thus, in designing the treatment strate-
gies for tailored towards individuals with poor CVH, an 
algorithm of SHS along with ideal CVH metrics assess-
ment could be an effective preventive strategy for CVD, 
from the perspective of PPPM.
Treatment algorithm tailored to individual at risk 
of mental health
Mental health complaint is one of central domain of SHS. 
Associations of SHS with psychological symptoms [157] 
reduced cognitive function [153] and increased incidence 
of self-reported suicidal ideation [154] has been reported 
amongst a Chinese population. In a cross-sectional study, 
prevalence of SHS was 21.0% amongst college stu-
dents and the independent factors such as somatisation 
(aOR) = 3.185, 95% CI (2.048–4.953), obsessive–compul-
sive (aOR = 3.518, 95% CI (2.834–4.368), interpersonal sen-
sitivity (aOR = 1.883, 95% CI (1.439–2.463), and depression 
(aOR = 1.847, 95% CI (1.335–2.554) were significantly asso-
ciated with SHS students [157]. In another study, SHS Chi-
nese individuals had approximately threefold increased odds 
of cognitive impairment. Early signs of high SHS score with 
poor cognitive, behavioural, and emotional wellbeing calls 
for the need to initiate preventive and personalised medical 
care against mental disorders. While the aetiology of poor 
mental health complaints is multifactorial, ineffective man-
agement may lead to irreversible damage and degeneration 
of neuronal systems [7, 155, 158]. Hence, PPPM is the way 
for future medical care for mental illness.
Treatment algorithm tailored to cancer 
management
Globally, prostate cancer is the one of the multifactorial 
cancers in men. Whilst the aetiology is multifactorial, 
improving diagnostics and treatments in the prostate can-
cer management causes an impressive divergence between, 
on one hand, permanently increasing numbers of diagnosed 
prostate cancer cases and, on the other hand, stable or even 
slightly decreasing mortality rates [4]. However, time of 
prostate cancer diagnosis is usually delayed. The emer-
gence of PPPM is the way forward for medical approach as 
this concept can early identify men who may have benign 
symptoms and are at risk of developing cancers. Prostate 
cancer patients are benefiting a lot from personalisation of 
medical services: the general approach by the radical castra-
tion has been revised for several subtypes of prostate cancer, 
since keeping urinary and sexual functions intact allows for 
significantly higher quality of life for many prostate cancer 
patients without diminishing the survival rates [4].
Hepatocellular carcinoma (HCC) is ranked as the fifth 
most common cancer but the second leading cause of all 
cancer-related mortalities [159]. This has been due to lack of 
effective screening programs and consequently late diagno-
sis, multifactorial origin with cumulative risk factors, com-
plex carcinogenesis, tumour heterogeneity, unpredictable 
impacts of individual microenvironment on tumour devel-
opment and progression, and, as the consequence, frequently 
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untargeted therapy and cancer resistance towards currently 
applied treatment approaches [159]. Currently the “wait and 
treat” approach is inappropriate in the overall hepatocellular 
carcinoma management. Since SHS has been associated with 
several non-communicable diseases, a treatment algorithm 
tailored towards individual at risk of prostate cancer and 
hepatocellular carcinoma would require prior assessment of 
SHS. Thus, urgent need in paradigm change towards PPPM 
is the suggested approach. Since early detection followed by 
appropriate intervention is important for prevention from 
the onset of diseases, it is demanded for clinicians to shift 
from the perspective of delayed intervention approach to 
early screening of individuals with SHS [31]. Thus, treat-
ment algorithms tailored towards individuals, as suggested 
in PPPM is the future approach to reducing the risk of non-
communicable diseases.
Outlook: conventional and traditional 
medicine – a “Hand‑in‑Hand” collaboration 
benefiting the patient and healthcare 
at large
Modern medicine, also referred to as “Western medicine”, 
“standard medicine”, or “conventional medicine” is “evi-
dence based” to penetrate phenotypes and to unravel the 
transcendent truth, and it has been nourished by the constant 
tension between the unknown and known, and imperfect and 
perfect [160, 161]. Modern medicine has been committed 
to the establishment of the standardised guidelines for the 
diagnosis followed by the prescription of therapies to allevi-
ate symptoms of disease [162]. However, the same diagnosis 
can derive from various molecular pathologies; therefore, 
different therapeutic strategies may be optimal for each indi-
vidual patient. Furthermore, if the alteration in molecular 
pathways for the disease can be identified at an early stage, 
then corrective measures can be initiated even before any 
symptoms of the disease develop, resulting in either delayed 
onset, or complete prevention of the disease from the per-
spectives of PPPM [18].
Traditional medicine, also called “Eastern medicine”, 
“complementary medicine” or “alternative medicine”, is 
“experience based” to pay more attention to the overall state 
of the individual, including general stress and physical and 
psychological conditions [18]. The WHO defines traditional 
medicine as “the sum total of the knowledge, skills, and 
practices based on the theories, beliefs, and experiences 
indigenous to different cultures, whether explicable or not, 
used in the maintenance of health as well as in the preven-
tion, diagnosis, improvement or treatment of physical and 
mental illness” [163]. Due to the different origins and cul-
tures, traditional medicine comprises a range of ancient, 
long-standing but still evolving treatment approaches 
being practised mainly in their countries of origin as well 
as in countries into which corresponding expertise has 
been “imported” [164]. In traditional medicine, treatment 
approaches consist of five categories listed in Table 5 with 
examples [165].
The fundamental principles of most traditional medicine, 
such as Ayurveda [166], Bush medicine [167], traditional 
Chinese medicine (TCM) [160], and Unani Tibb (“Greek 
Medicine” in Arabic) [168], are all to seek to invoke and 
restore balance of the elements of the body. For example, 
TCM believes that balances of “Yin” and “Yang” can keep 
body’s health [33]. The pattern describes the patient’s body 
as being in a situation of “distress” or “imbalance”, and 
illnesses arise through the pattern imbalance [33, 161]. 
Thereby, TCM specifies a terminology of “pattern of dis-
harmony” that gathers and weaves all information about 
physical and psychological conditions, including the pre-
sented symptoms, lost function and adaptability, as well 
as the patient's other general characteristics [18, 161]. The 
therapy then attempts to bring the configuration into bal-
ance, to restore harmony to the individuals’ [160]. However, 
traditional medicine lacks the molecular mechanisms and 
scientific proofs for the therapeutic effects on patients.
Integrative medicine — Eastern medicine meets 
Western medicine
Integrative medicine is an approach of combining modern 
and traditional medicine in a coordinated way that has been 
scientifically proven to be safe and effective [165, 169]. This 
approach emphasises the patient’s preferences while also it 
attempting to address the mental, physical, and spiritual ele-
ments of wellness and health [165]. Integrative health addi-
tionally stresses multimodal interventions, which are at least 
two interventions like conventional medicine, health-pro-
moting lifestyle, physical rehabilitation, psychotherapy, and 
complementary health techniques in various combinations, 
with an emphasis on treating the whole person rather than, 
for example, one organ system. Integrative health strives to 
achieve well-coordinated care across various providers and 
institutions by combing conventional and complementary 
approaches to really focus in the general individual [170] 
(Fig. 10).
With the goal of building the bridge between modern and 
traditional medicine, we coined the concept of “Suboptimal 
Health Status” (SHS) via the unique expertise of TCM to 
address the intermediate physical condition between health 
and disease from the viewpoint of PPPM [18, 20]. Mean-
while, by combining the merits of both modern medicine 
and TCM principles, we developed a reliable, valid and 
robust tool called the “SHSQ-25” to measure SHS and sup-
port greater personalisation in preventative health care [21, 
27, 29]. Further we achieved a linguistically valid translation 
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of the SHSQ-25 into Arabic, Chinese, English, Japanese, 
Korean, Portuguese, Russian, and Thai to overcome lan-
guage barriers and enhance the power of the tool for further 
expanded application in a greater number of populations. 
The innovative hybrid approaches utilise advantages of both 
modern medicine and TCM; furthermore, the combination 
of these two disciplines benefit patients and enrich the spec-
trum of tools and overall expertise of the dedicated profes-
sional groups assuring the reproducibility of TCM technolo-
gies and outcomes [15].
SHS is a new health dimension for translational medicine 
via the practical application of the SHSQ-25 in the gen-
eral population [20]. Studies have demonstrated that SHS is 
associated with an alteration of intestinal microbiota [171], 
telomere length [63], mRNA expression level of glucocor-
ticoid receptor α (GRα) [67], cardiovascular health met-
rics [23], plasma cortisol [172], plasma catechol-amines 
[67], oxidative stress [32], blood transcriptome profiling 
[173], metabolites [118], plasma N-glycans profiling [70], 
and biological ageing [63], with an increased incidence of 
cardiovascular diseases, type 2 diabetes mellitus (T2DM) 
[26], metabolic syndrome (MetS) [70], cancer [120], Par-
kinson’s disease [121, 122], systemic lupus erythematosus 
(SLE) [123], rheumatoid arthritis (RA) [124], dyslipidemia 
[125], hypertension [126], stroke [126], and preeclampsia 
[31]. Thereby, SHS plays an important role in the prediction 
of NCDs pathogenesis and progression.
Previous studies have revealed that SHS is mainly 
affected by lifestyle factors [174]. With the rapid advance-
ment of technology, changes in the environment, and peo-
ple’s lifestyles, the risk of SHS has steadily increased. 
Meanwhile, people are dealing with personal, familial, and 
societal stress, as well as a variety of obstacles including 
changes in their living environment, overwork, complex 
interpersonal relationships, sleep deprivation, excessive 
psychological stress, unbalanced diet, and inadequate exer-
cise [175]. Thus, PPPM strategies and prognosis for SHS 
are expected to become increasingly important. In the field 
of TCM, the mainstream and accepted forms of therapy 
include acupuncture, dietary therapy, herbal medicine, 
Table 5  Categories with examples of traditional medicine treatment approaches
Category Example Definition
Mind–body therapies Meditation Focused breathing or repetition of words or phrases to quiet the 
mind
Biofeedback Using simple machines, the patient learns how to affect certain 
body functions that are normally out of one's awareness (such as 
heart rate)
Hypnosis A state of relaxed and focused attention in which a person concen-
trates on a certain feeling, idea, or suggestion to aid in healing
Yoga Systems of stretches and poses, with special attention given to 
breathing
Tai Chi Involves slow, gentle movements with a focus on the breath and 
concentration
Imagery Imagining scenes, pictures, or experiences to help the body heal
Creative outlets Interests such as art, music, or dance
Biologically based practices Vitamins and dietary supplements Nutrients that are added to the diet
Botanicals plants or parts of plants
Manipulative and body-based practices Massage The soft tissues of the body are kneaded, rubbed, tapped, and 
stroked
Chiropractic therapy A type of manipulation of the spine, joints, and skeletal system
Reflexology Using pressure points in the hands or feet to affect other parts of the 
body
Biofield therapy Reiki Balancing energy either from a distance or by placing hands on or 
near the patient
Therapeutic touch Moving hands over energy fields of the body
Whole medical systems Ayurvedic medicine A system from India in which the goal is to cleanse the body and 
restore balance to the body, mind, and spirit
Traditional Chinese medicine Based on the belief that health is a balance in the body of two 
forces called “Yin” and “Yang”
Homoeopathy Uses very small doses of substances to trigger the body to heal 
itself
Naturopathic medicine Uses various methods that help the body naturally heal itself. An 
example would be herbal treatments
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moxibustion, massage, qigong (e.g., Tai Chi, Baduanjin, 
and Wuqinxi) applied singularly or in combination to treat 
and prevent diseases or maintain wellbeing [176, 177]. 
For instance, the evidence-based TCM treatment for SHS 
proved that Baduanjin exercise (one of the most common 
forms of Qigong consisting of eight separate, delicate, 
and smooth exercise movements) [135], moxibustion (a 
form of heat therapy in which dried plant materials called 
“moxa” are burned on acupoints) [138], and cupping 
(application of heated cups on the skin to remove stagna-
tion and stimulate the flow of “Qi”) [142] are valuable 
approaches for preventing SHS.
In conclusion, the early identification and prevention of 
SHS may both minimise prospective risk factors for SHS. 
This has the potential to not only improve the measures of 
the individuals’ quality of life and health outcome, but also 
serve to decrease the economic burden that non-commu-
nicable diseases place on healthcare systems worldwide. 
This successful hand-in-hand, modern meets tradition, 
west meets east, pattern of health care provides a compre-
hensive and holistic approach that benefits both individu-
als and global health care systems, as realised through the 
concepts of PPPM.
Concluding remarks and expert 
recommendations
The absolute majority of expanding non-communicable dis-
orders do carry a chronic character, over a couple of years 
progressing from reversible suboptimal health conditions to 
irreversible severe pathologies and cascading collateral com-
plications. The time-frame between onset of SHS and clini-
cal manifestation of associated disorders is the operational 
area for an application of reliable risk assessment tools and 
predictive diagnostics followed by the cost-effective targeted 
prevention and treatments tailored to the person. Particu-
larly in adolescence, the adverse health effects by subopti-
mal health carry reversible character. However, this unique 
capacity to repair health damage and to establish sustainable 
health supportive lifestyle habits is not adequately propa-
gated and not utilised by currently applied concepts of reac-
tive medical services [5].
This article demonstrates advanced strategies in bio/med-
ical sciences and healthcare focused on suboptimal health 
conditions in the frame-work of PPPM. Potential benefits 
in healthcare systems and for society at large include but 
are not restricted to an improved life-quality of populations 
and socio-economical groups, advanced professionalism of 
healthcare-givers, and sustainable healthcare economy.
Contextually, following programmes are recommended: 
innovative population screening programmes focused on 
stratified groups such as adolescents and young adults, 
planned pregnancies and post-partum, elite athletes, inten-
tional weight loss, low socio-economic status, and healthy 
elderly, amongst others.
For advanced risk assessment, purpose-adapted highly 
effective muti-level diagnostic tools are strongly recom-
mended such as specialised surveys, liquid biopsy and 
microbiome analysis, multi-omics, and comprehensive 
individualised patient profiling (CIPP) by application of 
artificial intelligence (AI, big data management, machine 
learning) [178–180].
Based on the CIPP, cost-effective preventive measures 
and treatments tailored to the person can be created con-
sidering individual risks and optimal medication options 
including natural substances and their derivatives [181].
The following healthcare areas are proposed to strongly 
benefit from the above proposed measures:
• Stress overload associated pathologies [156, 158, 182–
184]
• Planned pregnancies [8]
• Periodontal health [185]
• Eye disorders [5]
• Inflammatory disorders, wound healing and pain man-
agement with associated complications [186, 187]
Fig. 10  Western medicine meets Eastern medicine — acting hand-
in-hand in the frame-work of Predictive, Preventive and Personal-




• Metabolic disorders [2]
• Cardiovascular pathologies [178]
• Cancers [4]
• Stroke, particularly of unknown aetiology and in young 
individuals [7]
• Sleep medicine [188, 189]
• Individually suboptimal body weight [185, 188]
• Sports medicine [190]
• Male and female health [191]
• Improved individual outcomes under pandemic condi-
tions such as COVID-19 [185, 188, 192–194] amongst 
others [30, 190, 191].
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